These 20 women are 2018's Fiercest in the life sciences industry.
Read 2018's Fiercest Women in Life Sciences report!
Takeda is set to gulp up Shire whether disgruntled investors like the deal or not, but its new FDA OK may make it easier to swallow.
The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.…
Only about 1 percent of the population is naturally ambidextrous – the ability to accomplish tasks equally well with either hand.
Trial lawyer "bad drug" TV ads need better regulation, a new coalition of national patient and physician advocacy groups says.
Boehringer has teamed up for a second year with the Bonnie J. Addario Lung Cancer Foundation to bring holiday cheer directly to lung cancer patients.
Could an FDA-approved digital pill that communicates with your mobile phone upend healthcare? A new Executive Insights explains.
Investors sent J&J's shares down Friday after Reuters reported on court documents detailing the company's internal debates over asbestos in talc.
Teva has already decided to move its U.S. headquarters, and now it’s planning to move its worldwide headquarters, too.
Generic drug makers scored a win at the FDA as the agency changed its mind on giving them responsibility to update their labels.
Merck, one of the few Big Pharmas forging ahead in animal health, will plunk down €2.1 billion to move into digital tracking for livestock and pets.
India scrutinizes whistleblower case against Sun; FDA slaps warning letter on valsartan API maker; Eisai and UCL push anti-tau drug into the clinic.
AstraZeneca felt the blow last month when key trial Mystic failed. But now that the dust has settled, it's looking for bright spots in the miss.